Flowers Foods (FLO) Q3 2024 (Q&A) earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 (Q&A) earnings summary
3 Feb, 2026Executive summary
Strong branded bread performance led to market share gains and unit growth, even as the overall category softened and net sales for Q3 2024 decreased 0.7% year-over-year to $1.191 billion.
Net income rose by $111.7 million to $65.0 million, mainly due to lower legal settlements and a reduced tax rate, with adjusted EBITDA up 10.0% to $133.3 million.
Margin improvement was driven by portfolio strategy execution, cost savings, and improved OEE, despite consumer headwinds and increased promotional activity.
Fiscal 2024 guidance was narrowed, reflecting greater certainty and strong branded retail bread performance.
Strategic focus remains on enhancing shareholder value through growth in branded retail, margin improvement in private label and away-from-home businesses, and cost savings initiatives.
Financial highlights
Q3 2024 net sales were $1.191 billion, down 0.7% year-over-year, with price/mix up 1.7% and volume down 2.4%.
Net income for the quarter was $65.0 million, a significant improvement from a net loss of $46.7 million in the prior year quarter.
Adjusted EBITDA rose 10.0% year-over-year to $133.3 million, with margin up 110 basis points to 11.2%.
Gross margin improved as production costs as a percent of sales decreased to 50.2% from 51.5% for the quarter.
Year-to-date cash from operations was $282.4 million; capital expenditures $86.6 million; dividends paid $152.5 million.
Outlook and guidance
Fiscal 2024 net sales expected between $5.116 billion and $5.147 billion, with adjusted EBITDA guidance of $530 million to $542 million and adjusted diluted EPS of $1.24 to $1.28.
Capital expenditures projected at $130 million–$140 million, with $5–$7 million for ERP upgrades.
Optimization initiatives are projected to save $40–$50 million in Fiscal 2024.
Effective tax rate expected at approximately 25%.
Category pressures are expected to be temporary, with normalization anticipated at some point in 2025.
Latest events from Flowers Foods
- Q4 sales up 11% but net loss from $136M impairment; 2026 outlook cautious amid headwinds.FLO
Q4 2025 Prepared Remarks25 Feb 2026 - Q4 sales up 11% but net loss from impairment; 2026 outlook cautious amid headwinds.FLO
Q4 2025 (Q&A)13 Feb 2026 - Net income up 5% and EBITDA up 7.8% on margin gains, despite flat sales and ongoing cost pressures.FLO
Q2 2024 (Q&A)23 Jan 2026 - Net income and margins rose in Q2 2024, with FY guidance reaffirmed and cost savings ongoing.FLO
Q2 2024 Prepared Remarks23 Jan 2026 - Innovation, cost discipline, and premium growth drive strong performance amid market shifts.FLO
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - Net income rose to $65M on margin gains and lower legal costs, offsetting a 0.7% sales dip.FLO
Q3 2024 Prepared Remarks15 Jan 2026 - $795M deal expands better-for-you snacking, with EPS accretion expected by 2026.FLO
M&A Announcement10 Jan 2026 - Innovation, M&A, and brand leadership drive growth amid evolving consumer and market trends.FLO
Barclays 18th Annual Global Consumer Staples Conference 202531 Dec 2025 - Margin recovery and growth driven by inventory discipline, innovation, and accretive M&A.FLO
Raymond James & Associates’ 46th Annual Institutional Investors Conference 202523 Dec 2025